A Study to Evaluate the Efficacy and Safety of AD-224
The purpose of this study is to evaluate the efficacy and safety of AD-224
- EligibilityCriteria: Inclusion Criteria:  Signed informed consent Patients with Essential Hypertension Other inclusions applied  Exclusion Criteria:  Patient with Secondary Hypertension Other exclusions applied - HealthyVolunteers: No - Gender: All - MinimumAge: 19 Years - StdAgeList: Adult, Older Adult